KALA BIO, Inc.
KALANasdaqCIK 1479419HealthcareFiscal year ends Dec 31
Reports and events: 198 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-2420:10 ET | DEF 14A | Proxy statementPeriod 2026-11-03 | 0001829126-26-010384 |
| 2026-09-1021:24 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001829126-26-009999 |
| 2026-09-0921:06 ET | 8-K | 5.08 Item not in the standard list; 8.01 Other events | 0001829126-26-009946 |
| 2026-08-2810:45 ET | 8-K | 3.01 Delisting notice | 0001829126-26-009454 |
| 2026-08-1920:16 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001104659-26-098783 |
| 2026-07-2300:13 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001829126-26-007760 |
| 2026-07-0221:37 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001829126-26-007224 |
| 2026-05-1519:30 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001104659-26-062397 |
| 2026-05-0720:07 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001829126-26-004744 |
| 2026-04-1520:03 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001104659-26-043782 |
| 2026-03-0414:16 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure | 0001829126-26-001911 |
| 2026-02-2021:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001829126-26-001534 |
| 2026-02-0621:14 ET | SCHEDULE 13D | Ownership report, active investor | 0001829126-26-001059 |
| 2026-02-0521:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001829126-26-000995 |
| 2026-02-0211:01 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001829126-26-000837 |
| 2026-01-2321:05 ET | 8-K | 3.01 Delisting notice | 0001829126-26-000502 |
| 2026-01-0821:07 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001829126-26-000110 |
| 2026-01-0612:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001829126-26-000055 |
| 2026-01-0221:15 ET | 8-K | 8.01 Other events | 0001829126-26-000023 |
| 2025-12-3021:12 ET | DEF 14A | Proxy statementPeriod 2026-01-30 | 0001829126-25-010356 |
| 2025-12-2921:52 ET | 8-K | 4.01 Change of auditor; 5.02 Departure or appointment of officers or directors | 0001829126-25-010330 |
| 2025-12-1618:28 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001829126-25-010045 |
| 2025-12-1614:32 ET | 8-K | 5.08 Item not in the standard list; 8.01 Other events; 9.01 Financial statements and exhibits | 0001829126-25-010037 |
| 2025-12-0521:05 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001829126-25-009747 |
| 2025-11-2521:15 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001829126-25-009432 |
| 2025-11-1912:26 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001104659-25-113927 |
| 2025-11-1221:01 ET | 8-K | 3.01 Delisting notice | 0001104659-25-110316 |
| 2025-11-1013:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events | 0001104659-25-108844 |
| 2025-10-2012:00 ET | 8-K | 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001104659-25-100620 |
| 2025-10-1522:24 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-25-240483 |
| 2025-10-0200:37 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-096281 |
| 2025-10-0220:15 ET | 8-K/A | 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-096071 |
| 2025-10-0123:31 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-25-227218 |
| 2025-10-0112:00 ET | 8-K | 2.04 Item not in the standard list | 0001104659-25-095342 |
| 2025-09-2912:08 ET | 8-K | 2.05 Exit or disposal costs; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-094125 |
| 2025-09-1820:24 ET | 8-K | 5.08 Item not in the standard list; 8.01 Other events | 0001104659-25-091272 |
| 2025-09-0212:08 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-086011 |
| 2025-08-0812:06 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001558370-25-010853 |
| 2025-08-0812:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-010850 |
| 2025-07-0912:08 ET | 8-K | 8.01 Other events | 0001104659-25-066593 |
| 2025-05-1420:22 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001558370-25-007763 |
| 2025-05-1412:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-007664 |
| 2025-04-1120:09 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-034210 |
| 2025-03-3112:03 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001558370-25-004081 |
| 2025-03-3112:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-004080 |
| 2025-02-1213:06 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-25-011852 |
| 2024-12-3121:18 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-24-132857 |
| 2024-12-3014:10 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-132308 |
| 2024-11-1221:01 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001558370-24-015302 |
| 2024-11-1213:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-015168 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:08 ET. Listed shows no prices and gives no investment advice.